| 汤敏敏,刘建中,武志芳,等.分化型甲状腺癌患者131I治疗后体内残留放射性活度的评估[J].中华放射医学与防护杂志,2015,35(4):299-302.Tang Minmin,Liu Jianzhong,Wu Zhifang,et al.Estimation of residual activity in patients with differentiated thyroid cancer after administration of 131I for therapy[J].Chin J Radiol Med Prot,2015,35(4):299-302 |
| 分化型甲状腺癌患者131I治疗后体内残留放射性活度的评估 |
| Estimation of residual activity in patients with differentiated thyroid cancer after administration of 131I for therapy |
| 投稿时间：2014-07-26 |
| DOI：10.3760/cma.j.issn.0254-5098.2015.04.016 |
| 中文关键词: 分化型甲状腺癌 131I 放射性活度 尿液 剂量当量率 |
| 英文关键词:Differentiated thyroid cancer 131I Radioactivity Urine Equivalent dose rate |
| 基金项目: |
|
| 摘要点击次数: 5090 |
| 全文下载次数: 3284 |
| 中文摘要: |
| 目的 评估分化型甲状腺癌(DTC)患者131I治疗后体内残留放射性活度.方法 本次前瞻性研究包括49例DTC患者,分为“清甲”(131I摧毁术后残留的甲状腺组织)与“清灶”(131I治疗甲状腺床残留甲状腺癌、甲状腺床复发灶和转移灶)组,于服131I后收集患者每次排泄尿液,测定患者每天每次通过尿液排泄的放射性活度及排泄的总放射性活度,进而估算患者体内残留的放射性活度.分别于服131I后2、6、24、48、72 h进行1 m处剂量当量率的测定,估算患者体内残留放射性活度达到400 MBq时1 m处剂量当量率.结果 服131I后2、6、24、48、72 h体内残留131I活度占服131I初始活度的百分比,“清甲”组分别为99%、72%、25%、15%、7%,1 m处剂量当量率分别为157、120、35、11、9 μSv/h;"清灶"组对应百分比分别为99%、71%、18%、7%、3%,1 m处剂量当量率分别为232、182、48、11、2 μSv/h.体内残留的放射性活度与1 m处剂量当量率呈正相关(r=0.94,P<0.001).“清甲”与“清灶”组服131I后48~72 h体内残留放射性活度分别为548~259及451~248 MBq,对应的1 m处剂量当量率为8~10 μSv/h.结论 DTC患者于服131I后48~72 h体内残留放射性活度达到国家标准规定的400 MBq,即DTC患者1 m处剂量当量率达到8~10 μSv/h方可出院. |
| 英文摘要: |
| Objective To estimate the residual activity in patients with differentiated thyroid cancer (DTC) after administration of 131I for post-operative therapy. Methods Forty-nine DTC patients were divided into two groups (thyroid remnant 131I ablation therapy group and group with 131I treatment for recurrent and metastatic lesions). Urine excretion of 49 patients with differentiated thyroid cancer after 131I therapy was collected every time, with the activity of urine excretion and total activity calculated, and then residual activity in patients estimated. The determination of equivalent dose rate at 1 meter point were performed to estimate multi-temporal residual activity in each patient at 2, 6, 24, 48, and 72 h after administration of therapeutic doses of 131I, respectively. The equivalent dose rate at 1 meter point was indirectly estimated when the residual activity reach to 400 MBq. Correlation and regression were used to evaluate the relationship between residual activity and the equivalent dose rate at 1 m. Results The percentage of residual activity at 2, 6, 24, 48, and 72 h after administration of 131I, was, respectively, 99%, 72%, 25%, 15% and 7% in patients who have undergone thyroid remnant 131I ablation, and 99%, 71%, 18%, 7% and 3% in those who have undergone 131I treatment for metastatic lesions. The equivalent dose rate at 1 m point was, respectively, 157, 120, 35, 11 and 9 μSv/h in the former and 232, 182, 48, 11 and 2 μSv/h in the latter. There is a positive correlation between residual activity and equivalent dose rate at 1 m (r=0.94, P<0.001). The residual activity at 48-72 h after administration of 131I was, respectively, 548-259 MBq in the former and 451-248 MBq in the latter. The corresponding equivalent dose rate at 1 m ranged from 8 to 10 μSv/h. Conclusions The in vivo residual activity reaches the national standard of 400 MBq (10.8 mCi) in patients with differentiated thyroid cancer during 48-72 h after administration of 131I and the equivalent dose rate at 1 m ranged from 8 to 10 μSv/h. At this time, radiation isolation could be released. |
| HTML 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|